NYSE - Nasdaq Real Time Price USD

Smith & Nephew plc (SNN)

24.45

+0.57

(+2.39%)

At close: 4:00 PM EDT

24.45

-0.00

(-0.02%)

After hours: 4:00 PM EDT

With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners

Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...

Simply Wall St. 4 days ago

SNN
+2.39%
SNNUF
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention

Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip

GlobeNewswire 8 days ago

SNN
+2.39%
SNNUF
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT™ is designed to suit busy surgeons -

GlobeNewswire 18 days ago

SNN
+2.39%
SNNUF
Here’s Why You Should Invest in Smith & Nephew plc (SNN)

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]

Insider Monkey 18 days ago

SNN
+2.39%
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT). NICE have reviewed ‘Medical Technology Guideline 43 PICO negative pressure wound dressings for closed surgical incisions’ which recognises that Smith+Nephew’s PICO sNPWT provides better clinical outcomes than standard dressings

GlobeNewswire 22 days ago

SNN
+2.39%
SNNUF
Investors five-year losses continue as Smith & Nephew (LON:SN.) dips a further 5.6% this week, earnings continue to decline

For many, the main point of investing is to generate higher returns than the overall market. But every investor is...

Simply Wall St. 23 days ago

SNN
+2.39%
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact allowing it to be easily carried or worn,1 it features a discreet canister, and operates quietly so as not to draw attention or disturb the patients’ daily activities.1 It is estimated that the annual financial burden of ch

GlobeNewswire 25 days ago

SNN
+2.39%
SNNUF
Smith & Nephew PLC's Dividend Analysis

Smith & Nephew PLC (NYSE:SNN) recently announced a dividend of $0.46 per share, payable on 2024-05-22, with the ex-dividend date set for 2024-04-01. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's delve into Smith & Nephew PLC's dividend performance and assess its sustainability.

GuruFocus.com 25 days ago

SNN
+2.39%
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports. Under the terms of the multi-year partnership, Smith+Nephew will activate its brand through UFC’s immense global presence to promote the repair, regeneration and recovery of Sports Medicine injuries through advanced technologies

GlobeNewswire last month

SNN
+2.39%
SNNUF
Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...

Simply Wall St. last month

SNN
+2.39%
7 Robotic Surgery Stocks to Buy for the Future of Healthcare

There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes. I think that investing in robotic surgery stocks is an underrated thematic choice for investors. The reason being is that there is currently a very low industry penetration of using robots in the surgical market, which means ther

InvestorPlace last month

ISRG

GMED
+0.36%
SNN
+2.39%
Smith & Nephew plc Just Missed EPS By 38%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Smith & Nephew plc ( LON:SN. ) filed its annual result this time last week. The...

Simply Wall St. last month

SNN
+2.39%
Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript

Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript February 28, 2024 Smith & Nephew plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Deepak Nath: Good morning and welcome to the Smith & Nephew Q4 and Full Year ‘23 […]

Insider Monkey last month

SNN
+2.39%
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR). This marks the first time that the USAISR has entered into a master agreement of this nature with an industry-leading medical technology company. The Master CRADA represents an enterprise-wide opportunity for Smith+Nephew across all business units - Advanced Wound

GlobeNewswire last month

SNN
+2.39%
SNNUF
Basic Materials Roundup: Market Talk

Find insight on Zambia’s copper export earnings, Croda International, Pilbara Minerals, and more in the latest Market Talks covering the Basic Materials sector.

The Wall Street Journal last month

SNN
+2.39%
SNNUF
Health Care Roundup: Market Talk

Find insight on Hims & Hers Health, Novo Nordisk, Smith & Nephew, and more in the latest Market Talks covering the Health Care sector.

The Wall Street Journal last month

SNN
+2.39%
SNNUF

RAFLF
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 2 months ago

SNN
+2.39%
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 2 months ago

PAHC

SNN
+2.39%
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D Planning Software and Patient Specific Instrumentation for total shoulder arthroplasty. Total shoulder arthroplasty is one of the fastest growing segments in Orthopaedics with an estimated 250,000 procedures in the US by 2025.1 Developed to restore patients’ range-of-motion2-5 and he

GlobeNewswire 2 months ago

SNN
+2.39%
SNNUF
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* for its CORI◊ Surgical System, this exclusive image-agnostic* robotic-assisted surgical solution is designed to further help personalize surgery, advance efficiencies, and optimize performance across Smith+Nephew’s orthopaedic reconstruction portfolio. The power of one robotic-assisted platformSmith+N

GlobeNewswire 2 months ago

SNN
+2.39%
SNNUF

Performance Overview

Return	SNN	FTSE 100
YTD	-8.71%	+5.26%
1-Year	-20.00%	+3.15%
3-Year	-35.87%	+17.31%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Smith & Nephew plc (SNN)

With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

Here’s Why You Should Invest in Smith & Nephew plc (SNN)

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

Investors five-year losses continue as Smith & Nephew (LON:SN.) dips a further 5.6% this week, earnings continue to decline

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

Smith & Nephew PLC's Dividend Analysis

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

7 Robotic Surgery Stocks to Buy for the Future of Healthcare

Smith & Nephew plc Just Missed EPS By 38%: Here's What Analysts Think Will Happen Next

Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript

Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement

Basic Materials Roundup: Market Talk

Health Care Roundup: Market Talk

Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting

Performance Overview